30 results
20-F
2019 FY
EX-12.1
TAK
Takeda Pharmaceutical Co
27 Jun 19
Annual report (foreign)
6:41am
to adversely affect the company’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material
20-F
2019 FY
EX-12.2
TAK
Takeda Pharmaceutical Co
27 Jun 19
Annual report (foreign)
6:41am
to adversely affect the company’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material
6-K
EX-1
srb0p9x0zjpd4s7dyun
27 May 20
Current report (foreign)
6:03am
6-K
EX-99.1
9mo01v i45xf2gdt
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
tfe8xwc8t8uqkd612
30 May 23
Current report (foreign)
6:11am
6-K
EX-99.1
usuucwo8uzq ike
28 May 21
Current report (foreign)
6:01am
6-K
EX-99.1
qov27t
23 Jun 23
Current report (foreign)
6:13am
S-8
EX-99.1
j50n5s1 pp4oqhs
25 Jun 20
Registration of securities for employees
6:21am
6-K
vm9nhh
30 May 19
Current report (foreign)
10:26am
6-K
o1aw1i4v4ri1ssapiu4l
24 Jun 20
Current report (foreign)
3:31pm
DRS/A
fgf knrm0
16 Nov 18
Draft registration statement (amended)
12:00am